JOSE FRANCISCO RIVERA BENITEZ

Dr. JOSE FRANCISCO RIVERA BENITEZ

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2017 in Virus Genes
Verified
Journal Article
Closed access
PDF file
RLRocío Lara-Romero
Rocío Lara-Romero
LGLuis Gómez-Núñez
Luis Gómez-Núñez
JCJosé Luis Cerriteño-Sánchez
José Luis Cerriteño-Sánchez
LMLaura Márquez-Valdelamar
Laura Márquez-Valdelamar
SMSusana Mendoza-Elvira
Susana Mendoza-Elvira
JBJOSE FRANCISCO RIVERA BENITEZ
JOSE FRANCISCO RIVERA BENITEZ

10 April 2014 in Avian Pathology
Verified
Journal Article
Closed access
JBJOSE FRANCISCO RIVERA BENITEZ
JOSE FRANCISCO RIVERA BENITEZ
RMRebeca Martínez-Bautista
Rebeca Martínez-Bautista
FRFrancisco Ríos-Cambre
Francisco Ríos-Cambre
HRHumberto Ramírez-Mendoza
Humberto Ramírez-Mendoza
We conducted a longitudinal study to detect and isolate avian metapneumovirus (aMPV) in two highly productive poultry areas in Mexico. A total of 968 breeder hens and pullets from 2 to 73 weeks of age were analysed. Serology was performed to detect aMPV antibodies and 105 samples of tracheal tissue were collected, pooled by age, and used for attempted virus isolation and aMPV nested reverse transcriptase-polymerase chain reaction (nRT-PCR). The serological analysis indicated that 100% of the sampled chickens showed aMPV antibodies by 12 weeks of age. Five pools of pullet samples collected at 3 to 8 weeks of age were positive by nRT-PCR and the sequences obtained indicated 98 to 99% similarity with the reported sequences for aMPV subtype A. Virus isolation of nRT-PCR-positive samples was successfully attempted using chicken embryo lung and trachea mixed cultures with subsequent adaptation to Vero cells. This is the first report of detection and isolation of aMPV in Mexico.

30 August 2013 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
LRLuis A. Ramírez‐Martínez
Luis A. Ramírez‐Martínez
MCMaría Contreras‐Luna
María Contreras‐Luna
JLJazmín De la Luz
Jazmín De la Luz
MMMaría E. Manjarrez
María E. Manjarrez
DRDora P. Rosete
Dora P. Rosete
HRHumberto Ramírez-Mendoza
Humberto Ramírez-Mendoza
Background: The possible transmission of influenza A virus between dogs and humans is important, as in Mexico City there are approximately 1·2 million dogs. We present the first evidence of influenza A virus infection in household dogs in Mexico.Objectives: The objective of this study was to identify the presence of antibodies against influenza A virus in dogs and their owners, as well as the presence of RNA of influenza A virus in nasal exudates of dogs and, thereby, assess the possible transmission of the virus between humans and dogs.Methods: Serum samples from household dogs and their owners were analyzed to detect the presence of antibodies against three subtypes of human influenza virus (H1N1pdm09, H1N1, and H3N2), as well as subtype H3N8 of equine influenza. We analyzed dog nasal exudates to detect influenza viral RNA. The relationship between the seropositivity of dogs and various factors (age, sex, constantly at home, and seropositivity of owners) was statistically analyzed.Results: Seroprevalence for human influenza in dogs was 0·9% (1 of 113), and it was 4% (5 of 113) for equine influenza. In humans, seroprevalence was 22% for subtype H1N1pdm09, 20% for subtype H1N1, and 11% for subtype H3N2. No significant association (P > 0·05) was found between seropositivity and any of the assessed factors. Furthermore, no viral RNA was detected in the nasal exudate samples.Conclusions: Results revealed seroprevalence of the influenza virus in household dogs in Mexico City. It can be assumed that dogs are currently becoming infected with different subtypes of influenza viruses.

16 December 2011 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
AEA. C. Escobar-López
A. C. Escobar-López
JBJOSE FRANCISCO RIVERA BENITEZ
JOSE FRANCISCO RIVERA BENITEZ
HCH. Castillo-Juárez
H. Castillo-Juárez
HRH. Ramírez-Mendoza
H. Ramírez-Mendoza
MTMaría Elena Trujillo-Ortega
María Elena Trujillo-Ortega
JSJose Ivan Sanchez-Betancourt
Jose Ivan Sanchez-Betancourt
We sampled sera from 1013 non-vaccinated swine from four states in Mexico, Guanajuato, Jalisco, Michoacán and the Estado de Mexico, to analyse anti-porcine rubulavirus antibody titres against three different porcine rubulavirus isolates (PAC-4/1993, PAC-6/2001, and PAC-9/2003) using a hemagglutination inhibition assay. The results revealed that there were antigenic differences among the isolates assessed. In particular, the estimated correlation between the PAC-4/1993 and PAC-6/2001 (0.50) isolates and between the PAC-4/1993 and PAC-9/2003 isolates (0.56) displayed a moderate positive correlation. In contrast, there was a strong positive correlation between the PAC-6/2001 and PAC-9/2003 isolates (0.73). We also found that in the state of Guanajuato, PAC-4/1993 was the isolate that was most frequently identified; in Jalisco, the isolate was PAC-6/2001; and in Michoacán, the isolate was PAC-9/2003. By contrast, in the Estado de Mexico, all three isolates appeared to circulate with a low seroprevalence. In general, the analysed sera from the four states displayed a porcine rubulavirus serological prevalence ranging from 9% to 23.7%. These data indicate that there is not complete antibody cross-antigenicity among the three isolates, and the antigenic variations in the antibody response found in this study implies that the use of a monovalent vaccine would not generate complete protection against the different antigenic subtypes.

9 November 2021 in Revista Mexicana de Ciencias Pecuarias
Verified
Journal Article
Open access
PDF file
JBJOSE FRANCISCO RIVERA BENITEZ
JOSE FRANCISCO RIVERA BENITEZ
JLJazmín De la Luz-Armendáriz
Jazmín De la Luz-Armendáriz
LGLuis Gómez-Núñez
Luis Gómez-Núñez
FVFernando Diosdado Vargas
Fernando Diosdado Vargas
GEGuadalupe Socci Escatell
Guadalupe Socci Escatell
MMManuel Zapata Moreno
Manuel Zapata Moreno
En los sistemas de producción porcina, uno de los puntos críticos que deben ser atendidos con estricto rigor, es la salud de los cerdos. La salud, es un componente estructural del bienestar animal y refleja un estado óptimo de los animales, lo que repercute directamente en un mayor desempeño productivo y mejores condiciones de desarrollo. Uno de los eslabones más frágiles de la salud de los cerdos, es la presencia de enfermedades infecciosas más importantes, las cuales pueden representar pérdidas hasta del 100 % de la producción, por lo cual, debe ser un tema de atención constante, y continuamente vigilado por el Médico Veterinario Zootecnista y los productores, en perfecta coordinación con las autoridades sanitarias oficiales. En la actualidad, la implementación de mejores prácticas en la cadena productiva es de interés para productores y consumidores. El control de las enfermedades infecciosas debe ser un tema de colaboración entre los diferentes actores del entorno y ser considerado un bien público, ya que las repercusiones negativas, pueden ser desde el nivel local hasta mundial. En la presente revisión, se abordará la temática relacionada con las principales enfermedades infecciosas que ponen en riesgo la salud porcina, el impacto, las principales aportaciones realizadas por el Instituto Nacional de Investigaciones Forestales, Agrícolas y Pecuarias (INIFAP) en sus 35 años de vida, específicamente en el Centro Nacional de Investigación Disciplinaria en Salud Animal e Inocuidad (CENID-SAI), anteriormente conocido como el emblemático CENID-Microbiología o Palo Alto.

1 March 2013 in Veterinary Microbiology
Verified
Journal Article
Closed access
JBJOSE FRANCISCO RIVERA BENITEZ
JOSE FRANCISCO RIVERA BENITEZ
RMRebeca Martínez-Bautista
Rebeca Martínez-Bautista
APArmando Pérez-Torres
Armando Pérez-Torres
AGAdelfa del Carmen García-Contreras
Adelfa del Carmen García-Contreras
JRJulio Reyes-Leyva
Julio Reyes-Leyva
HRHumberto Ramírez-Mendoza
Humberto Ramírez-Mendoza